FLT3 testing and guideline concordance in Acute Myeloid Leukemia across an Indiana health system
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-7955
Abstract: Background: FLT3 mutations occur in approximately 30% of patients with acute myeloid leukemia (AML) and are associated with an adverse prognosis. Current guidelines recommend FLT3 mutation testing at diagnosis to inform risk stratification and guide… read more here.
Keywords: treatment; flt3 testing; flt3; flt3 mutations ... See more keywords